Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (321-330 of 655) with videos related to

Pageof 66
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancerM Mackean, A Planting, C Twelves, et al.
Molecular and Cellular Probes|August 10, 2010
Identification and delineation of members of the Entamoeba complex by pyrosequencingChristen R Stensvold, Marianne Lebbad, Jaco J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative GroupJ B Vermorken, J Verweij, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicityP J Perik, B Rikhof, F A de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancerR de Wit, M Tesselaar, T C Kok, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Experience with independent radiological review during a topotecan trial in ovarian cancerS Gwyther, G Bolis, M Gore, et al.
Archives of Medical Research|November 9, 2000
Differentiation of Entamoeba histolytica and Entamoeba dispar using PCR-SHELA and comparison of antibody responseJ J Verweij, L van Lieshout, C Blotkamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group studyD J Wagener, H E Verdonk, L Y Dirix, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapyM A Rudek, A Sparreboom, E S Garrett-Mayer, et al.
British Journal of Cancer|August 1, 1991
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistanceJ Verweij, H Herweijer, R Oosterom, et al.
Pageof 66

Showing results (321-330 of 655) with videos related to

Sort By:
Pageof 66
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancerM Mackean, A Planting, C Twelves, et al.
Molecular and Cellular Probes|August 10, 2010
Identification and delineation of members of the Entamoeba complex by pyrosequencingChristen R Stensvold, Marianne Lebbad, Jaco J Verweij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative GroupJ B Vermorken, J Verweij, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicityP J Perik, B Rikhof, F A de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancerR de Wit, M Tesselaar, T C Kok, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Experience with independent radiological review during a topotecan trial in ovarian cancerS Gwyther, G Bolis, M Gore, et al.
Archives of Medical Research|November 9, 2000
Differentiation of Entamoeba histolytica and Entamoeba dispar using PCR-SHELA and comparison of antibody responseJ J Verweij, L van Lieshout, C Blotkamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group studyD J Wagener, H E Verdonk, L Y Dirix, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapyM A Rudek, A Sparreboom, E S Garrett-Mayer, et al.
British Journal of Cancer|August 1, 1991
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistanceJ Verweij, H Herweijer, R Oosterom, et al.
Pageof 66